Dr Salil Mehta, Volunteer and Consultant Ophthalmologist with MSF, recently published a paper on optic neuropathy in DR-TB patients in Mumbai. He discusses key takeaways of his research with Sachin Jagdale.
Any specific reason behind selecting patients from Mumbai for Linezolid associated optic neuropathy in DR-TB patient study?
There is a combination of reasons. Firstly, MSF has an excellent and a well established TB/HIV clinic in Mumbai. Hence, the expertise is available. Secondly, and more importantly, Mumbai is a global hot spot for tuberculosis (TB). A perfect storm of several factors including extreme population densities, incorrect treatment and poor compliance are leading to high incidence of primary drug sensitive TB and subsequent drug resistance. Worryingly, an increasing number of patients are presenting with primary drug resistant tuberculosis. This makes Mumbai an ideal city to undertake such a study.
Can you take us through this entire study. (How and why was it started? Have you managed to achieve your targets?)
Ever since the use of linezolid became wide spread, available literature suggested potential ocular toxicity. Accordingly, the staff and doctors of MSF conducted primary screening and evaluation for all these patients. Suspect cases were then referred for further evaluation. These patients were fully evaluated, treated and followed up till resolution. It's an ongoing process and hopefully in a few years we will have more data for more research.
This story is from the October 16, 2016 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the October 16, 2016 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation